Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05828589
Title A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Monash Health RECRUITING Clayton Victoria 3168 Australia Details
Peking University Third Hospital RECRUITING Beijing Beijing 100000 China Details
Fujian Cancer Hospital RECRUITING Fuzhou Fujian 350014 China Details
Henan Cancer Hospital RECRUITING Zhengzhou Henan 450000 China Details
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology RECRUITING Wuhan Hubei 430030 China Details
The First Affiliated Hospital of Soochow University RECRUITING Suzhou Jiangsu 215006 China Details
The First Affiliated Hospital of Nanchang University Branch Donghu RECRUITING Nanchang Jiangxi 330006 China Details
Shengjing Hospital of China Medical University RECRUITING Shenyang Liaoning 110004 China Details
Shandong Provincial Hospital RECRUITING Jinan Shandong 250021 China Details
Affiliated Zhongshan Hospital of Fudan University RECRUITING Shanghai Shanghai 200032 China Details
Institute of Hematology and Hospital of Blood Disease RECRUITING Tianjin Tianjin 300020 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field